Profile | OTHERS

Logo	Name	Type	Year of Establishment	Industry Tag
	Fine Structure Ventures	Investor	2020
Hi we’re Fine Structure Ventures! Fine Structure Ventures is a Cambridge-based venture capital firm specializing in early-stage investments in deep scientific innovation, including synthetic biology. Their portfolio features companies like Constructive Bio, which engineers custom genomes for novel biomolecules, and Debut Biotech, utilizing cell-free biomanufacturing to produce sustainable ingredients for various industries.
	Paladin Capital	Investor	2001
Hi we’re Paladin Capital! Paladin Capital Group is a multi-stage investment firm backing synthetic biology innovators like Constructive Bio, which engineers custom genomes, and Twist Bioscience, a pioneer in high-throughput DNA synthesis. The firm is also expanding into digital biology, blending AI and biotech to accelerate next-generation therapeutics
	OMX Ventures	Investor	2020
Hi we’re OMX Ventures! OMX Ventures is an early-stage venture capital firm investing at the intersection of biology, big data, and AI, with a focus on synthetic biology platforms. Its portfolio includes Constructive Bio, advancing whole-genome writing, and Inscripta, streamlining CRISPR-based genome engineering
	Ahren Innovation Capital	Investor	2017
Hi we’re Ahren Innovation Capital! Ahren Innovation Capital is a deep tech-focused investment firm backing breakthrough synthetic biology startups. It has funded companies like Constructive Bio, which engineers custom genomes, and Rubedo Life Sciences, targeting age-related diseases.
	SevenVentures	Investor	2011	Food
Hi we’re SevenVentures! SevenVentures, the investment arm of ProSiebenSat.1 Media SE, specializes in media-for-equity investments to accelerate growth for B2C companies. While not directly focused on synthetic biology, it has invested in foodtech companies like Planted Foods GmbH, which develops plant-based meat alternatives .
	REWE Group	Others	1927
Hi we’re REWE Group! REWE Group, a major German retailer, has invested in synthetic biology through its participation in Infinite Roots' $58 million Series B funding round. Infinite Roots, formerly known as Mushlabs, specializes in developing sustainable food products using mushroom mycelium technology . Additionally, REWE Group has engaged in discussions on fermentation technology with startups like Formo and Infinite Roots, highlighting its commitment to sustainable food innovation.
	Foresite Capital	Investor	2011	Medical
Hi we’re Foresite Capital! Foresite Capital is a healthcare and life sciences investment firm that backs companies leveraging synthetic biology to transform medicine. Its portfolio includes Senti Bio and insitro, which apply synthetic biology and AI to engineer next-generation cell and gene therapies.
	Wellington Management	Investor	1933
Hi we’re Wellington Management! Wellington Management is a global investment firm with a strong presence in biotechnology and synthetic biology, supporting innovation in therapeutics and life sciences. Its investments include companies like Senti Bio and Ginkgo Bioworks, advancing gene circuits and cell programming technologies.